Navigation Links
Abaxis, Inc. to Present at the Sidoti & Company Twelfth Annual New York Emerging Growth Institutional Investor Forum
Date:3/19/2008

UNION CITY, Calif., March 19 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, CEO and President, will present at Sidoti & Company's Twelfth Annual New York Emerging Growth Institutional Investor Forum on Tuesday, March 25, 2008 at 11:00 a.m. ET. The conference will be held at The Grand Hyatt in New York City.

About Abaxis

Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.

Contact: Clint Severson

Chief Executive Officer

ABAXIS, Inc.

510-675-6500

Lytham Partners, LLC

Joe Dorame, Joe Diaz & Robert Blum

602-889-9700


'/>"/>
SOURCE Abaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Abaxis, Inc. to Present at the Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
2. Abaxis, Inc. to Present at the Fifth Annual Sidoti & Company Emerging Growth Conference
3. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
4. Transdel Pharmaceuticals to Present at Cowen and Companys 28th Annual Health Care Conference
5. Smart Balance to Webcast Presentation at Citi Small/Midcap Conference
6. Julia Quinlan to present awards at a conference hosted by Rutgers College of Nursing
7. Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference
8. Covance to Present at Lehman Brothers 11th Annual Global Healthcare Conference
9. Hologic to Present at Lehman Brothers Healthcare Conference
10. Bristol-Myers Squibb to Present at Healthcare Conferences
11. Exponent to Present at Sidoti and B. Riley Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2008)...- Inc. Magazine recently included,Connolly Consult...ing,private companies in the country. The list is ...segment of the economy -- America,s,independent-mi...ies,represent the backbone of the U.S. economy., ...03/NY36880LOGO ), Connolly Consulting,s consiste...
(Date:10/3/2008)... Discrimination; Recognizes,Importance of Mental H.../PRNewswire-USNewswire/ -- Mental Health,America t...approval of a,mental health parity legislation tha...ion against Americans with mental health and subst...lans., The legislation, which recognizes the impo...
(Date:10/3/2008)...search Foundation(R) Collection of, Bouquets to T...Research, LOS ANGELES, Oct. 3 /PRNewswire/ -- Tel...g only hand-arranged, hand-delivered floral,arrang...nth-long,collaboration with The City of Hope, John... Cancer Center in southern California and national...
(Date:10/3/2008)...- As the population ages, a big,question employers...e the,financial crunch of an illness?", In most c...eck to,paycheck and now need two incomes to provid... spouses becomes critically ill and unable to work...ut the healthy,employee/spouse is strained by the ...
Breaking Medicine News(10 mins):Health News:Connolly Consulting Makes the 2008 Inc. Magazine's List of America's 5000 Fastest Growing Companies 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 3Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 2Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 3Health News:Can Your Employees Survive the Financial Crunch of an Illness? 2
...nd to be effective in reducing chest pain, not ass...f patients with chest pain have no identifiable ca...e efforts by cardiologists, they continue to be se...icularly, young women seem be more prone to this c...
...that was conducted by the London School of Hygiene... pandemic across Europe, it was found that serious...tween countries existed. // The Czech Republic, It...gal were the least prepared. It is necessary that...
...d the largest outbreak of mumps over the past two ... country since 1988 // , is believed to have begun... federal officials reported yesterday that the out...ng to latest information from the U.S. Centres for...
...Queen's University and the University of Pennsylva... for drugs like Celebrex and Vioxx, administered f...otential risk of triggering a heart problem Co-aut...istry and Physiology at Queen's, and Canada Resear...
Other Medicine News:Health News:Non-Cardiac Chest Pain Can Be Treated By Hypnotherapy 2Health News:Joint Effort among Various Nations to Tackle Bird Flu 2Health News:Mumps Outbreak In The US 2Health News:Mumps Outbreak In The US 3
(Date:10/6/2008)...oncept of Other Product - Company,s Bioabsorbable ... HONG KONG, Oct. 6 /- Data from mult...ing stent, OrbusNeich,s Genous Bio-engineered R,st...ter Cardiovascular,Therapeutics symposium, TCT 200...Ph.D., of the Academic Medical Center in,Amsterdam...
(Date:10/5/2008)... published in New England Journal of Medicine reaf...y profile of SPIRIVA(R),HandiHaler(R), RIDGEFIELD...lts of the,UPLIFT (Understanding Potential Long-te...wed that SPIRIVA(R) HandiHaler(R) (tiotropium brom...lung function for up to 4,years as measured by FEV...
(Date:10/3/2008)...AM, October 3 /- Amsterdam ...n the field of human gene therapy,announced today...to the,Marketing Authorization Application (MAA) f...PLD), a seriously debilitating and potentially let...hase II clinical studies (22,patients in total) de...
(Date:10/3/2008)...nies to Study B-Raf Kinase Inhibitors for Cancer T... Oct. 3 /-,Eli Lilly and Co...harmaceuticals, LLC today announced that the two c...ldwide licensing agreement related to,Deciphera,s ... study of,potential oncology therapeutics., The c...
Breaking Medicine Technology:Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 2AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 3Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 2Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 3Support for Patient Navigation Services to Help Cancer Patients 17607 1Support for Patient Navigation Services to Help Cancer Patients 17607 2Oberthur Technologies XPon Offer 3032 1Oberthur Technologies XPon Offer 3032 2Nanotubes grown straight in large numbers 4824 1Nanotubes grown straight in large numbers 4824 2Nanotubes grown straight in large numbers 4824 3President Recognizes Sharp HealthCare With 2007 Malcolm Baldrige National Quality Award at White House 17601 1President Recognizes Sharp HealthCare With 2007 Malcolm Baldrige National Quality Award at White House 17601 2
...rch 2007 - Cancer drug,developer Antisoma plc (LSE...tial findings from its second, confirmatory phase ..., This 30-patient trial tested an 1800 mg/m2 dose ...itaxel chemotherapy.,Investigators reported a resp... disease stabilisation, while only 7% had,progress...
...earch UK scientists in Glasgow,have devised a new ...findings in the Journal of Clinical Investigation*... Beatson Institute for Cancer,Research gave mice a...de, significantly slowing the growth of the tumour...gene called p73 that brings,about cancer cell deat...
Other Medicine Technology:Antisoma plc (UK) - Second lung cancer trial adds to positive data,on AS1404 2Antisoma plc (UK) - Second lung cancer trial adds to positive data,on AS1404 3Scottish Scientists Test ‘Secret Weapon’ Against,Tumours 2Scottish Scientists Test ‘Secret Weapon’ Against,Tumours 3
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products: